Physician profile
Daniel E Otten
NPI 1508088162
$275.63
in general payments reported to CMS, 2019-2025
10 companies · $92.80 in 2025
The $92.80 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.51 · 2022: $54.55 · 2023: $17.01 · 2024: $94.76 · 2025: $92.80.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $205.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $204.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $55.94 | 2024 | Camzyos |
| Amgen INC. | $51.11 | 2025 | Repatha, Repatha |
| Pfizer INC. | $40.79 | 2023-2024 | |
| Novartis Pharmaceuticals Corporation | $21.39 | 2022 | |
| Inspire Medical Systems, INC. | $20.94 | 2025 | Inspire |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $20.75 | 2025 | Lifevest |
| Philips North America LLC | $17.35 | 2022 | |
| Novo Nordisk INC | $16.51 | 2019 | |
| Medtronic, INC. | $15.81 | 2022 | |
| Sanofi-Aventis U.S. LLC | $15.04 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Otten listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.